Abstract

Mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have made this virus more infectious. Previous studies have confirmed that non-structural protein 13 (NSP13) plays an important role in immune evasion by physically interacting with TANK binding kinase 1 (TBK1) to inhibit IFNβ production. Mutations have been reported in NSP13; hence, in the current study, biophysical and structural modeling methodologies were adapted to dissect the influence of major mutations in NSP13, i.e., P77L, Q88H, D260Y, E341D, and M429I, on its binding to the TBK1 and to escape the human immune system. The results revealed that these mutations significantly affected the binding of NSP13 and TBK1 by altering the hydrogen bonding network and dynamic structural features. The stability, flexibility, and compactness of these mutants displayed different dynamic features, which are the basis for immune evasion. Moreover, the binding was further validated using the MM/GBSA approach, revealing that these mutations have higher binding energies than the wild-type (WT) NSP13 protein. These findings thus justify the basis of stronger interactions and evasion for these NSP13 mutants. In conclusion, the current findings explored the key features of the NSP13 WT and its mutant complexes, which can be used to design structure-based inhibitors against the SARS-CoV-2 new variants to rescue the host immune system.

Highlights

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the newly emerged virus that causes coronavirus disease 2019 (COVID-19)

  • To determine whether non-structural protein 13 (NSP13) mutants, compared to their WT counterpart, could affect their interaction with TANK binding kinase 1 (TBK1), mutants P77L, Q88H, D260Y, E341D, and M429I were generated by Chimera (Figures 1A–F)

  • The superimposition of these generated mutants followed it on NSP13 WT, and root mean square deviation (RMSD) values were observed

Read more

Summary

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the newly emerged virus that causes coronavirus disease 2019 (COVID-19). Its genome contains 5 untranslated region (UTR), 3 UTR, and ORF1a/b that encode 16 non-structural proteins (NSPs), four structural proteins, i.e., spike, envelop, membrane, and nucleocapsid, and nine accessory proteins, which include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF9c, and ORF10 (Ribero et al, 2020). Severe acute respiratory syndrome coronavirus 2 suppresses the immune response of the host during the early phase of infection (Chu et al, 2020). SARS-CoV-2 replicates more efficiently than severe acute respiratory syndrome coronavirus (SARS-CoV) in alveolar macrophages and pneumocytes (both type I and type II) in ex vivo lung tissues. More investigations are required on innate immune suppression by SARS-CoV-2, which is associated with viral pathogenesis

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.